Oncoliq

When cancer is detected early

Oncoliq is a biotech company in Buenos Aires, Argentina. It has raised $2.8M across 1 round, most recently a $2.8M Seed in December 2024.

Headquarters
Buenos Aires
Employees
1–10
Business Model
B2B
Total Funding
$2.8M
Last Round
$2.8M SeedDec 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. to use credits for reveals, or explore the API.

About

Oncoliq is an Argentine biotech startup developing a multi-cancer early detection platform using liquid biopsy technology. The company's approach isolates and analyzes microRNAs from a small blood sample to screen for multiple cancer types simultaneously, with a focus on reducing cancer mortality through accessible, scalable screening. Co-founded by scientists Marina Simian (CEO) and Adriana De Siervi (CSO), Oncoliq is currently conducting clinical trials in partnership with leading Argentine hospitals and research institutions, and raised $2.84M in a seed round in 2025.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundDec 2024
$2.8M

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Frontend ×2
  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oncoliq on Indexed.vc
<a href="https://indexed.vc/companies/oncoliq"><img src="https://indexed.vc/api/badge/company/oncoliq" alt="Oncoliq on Indexed.vc" width="260" height="76" /></a>